Skip to main content

Privium Fund Management B.V.

SEC CIK
0001795097
Latest filing
Aug 7, 2026

Holdings in Q2 2025

Holdings as of Jun 30, 2025, filed Jul 30, 2025. Long positions only; changes compare share counts with Q1 2025.

Institution overview
Positions
55
−1 vs. Q1 2025
Portfolio value
$463.5M
+$79.9M (+20.8%) vs. Q1 2025
Filed
Jul 30, 2025
SEC
Holdings of Privium Fund Management B.V. in Q2 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
SPOTSpotify Technology S.A.Stock114,000$84.8M18.3%−31,000−21.4%ReducedHistory
TSLATesla, Inc.Stock242,000$74.7M16.1%+22,000+10.0%AddedHistory
SHOPShopify Inc.Stock430,000$49.0M10.6%+15,000+3.6%AddedHistory
PLTRPalantir Technologies Inc.Stock350,000$46.6M10.1%−10,000−2.8%ReducedHistory
AMZNAmazon Com IncStock149,000$32.8M7.1%+8,000+5.7%AddedHistory
SESea LtdSPONSORD ADS210,000$32.5M7.0%00.0%UnchangedHistory
COINCoinbase Global, Inc.COM CL A70,000$24.2M5.2%+70,000NewHistory
NVDANVIDIA CorpStock81,000$12.5M2.7%+8,000+11.0%AddedHistory
IONSIonis Pharmaceuticals IncCOM267,594$10.7M2.3%00.0%UnchangedHistory
PRQRProQR Therapeutics N.V.SHS EURO4,997,562$10.0M2.2%+11,929+0.2%AddedHistory
ARWRArrowhead Pharmaceuticals, Inc.COM612,214$9.85M2.1%−17,000−2.7%ReducedHistory
RAREUltragenyx Pharmaceutical Inc.COM253,304$9.18M2.0%+3,500+1.4%AddedHistory
QUREuniQure N.V.SHS447,486$6.26M1.4%−131,653−22.7%ReducedHistory
AXSMAxsome Therapeutics, Inc.COM52,732$5.43M1.2%00.0%UnchangedHistory
MRKMerck & Co., Inc.Stock59,093$4.83M1.0%+18,000+43.8%AddedHistory
ARQTArcutis Biotherapeutics, Inc.COM344,472$4.74M1.0%+18,763+5.8%AddedHistory
ZLABZai Lab LtdADR132,189$4.65M1.0%00.0%UnchangedHistory
VRTXVertex Pharmaceuticals IncStock8,300$3.75M0.8%00.0%UnchangedHistory
ACADAcadia Pharmaceuticals IncCOM148,400$3.17M0.7%00.0%UnchangedHistory
MRNAModerna, Inc.Stock103,433$2.97M0.6%+27,857+36.9%AddedHistory
BIIBBiogen Inc.COM20,500$2.67M0.6%+20,500NewHistory
CRSPCRISPR Therapeutics AGNAMEN AKT44,700$2.17M0.5%−15,397−25.6%ReducedHistory
ABEVAmbev S.A.SPONSORED ADR795,786$1.93M0.4%−8,420−1.0%ReducedHistory
CVNACarvana Co.CL A5,000$1.68M0.4%+5,000NewHistory
URGNUroGen Pharma Ltd.COM107,622$1.40M0.3%00.0%UnchangedHistory
ROIVRoivant Sciences Ltd.SHS126,923$1.39M0.3%00.0%UnchangedHistory
Avidity Biosciences, Inc.05370A108COM46,000$1.31M0.3%+11,500+33.3%Added–
KRYSKrystal Biotech, Inc.COM9,320$1.30M0.3%+1,810+24.1%AddedHistory
BNTXBioNTech SESPONSORED ADS10,987$1.18M0.3%+10,987NewHistory
RCKTRocket Pharmaceuticals, Inc.COM432,760$1.12M0.2%00.0%UnchangedHistory
HIMSHims & Hers Health, Inc.Stock22,000$1.10M0.2%+22,000NewHistory
MGTXMeiraGTx Holdings plcCOM163,000$1.06M0.2%+46,000+39.3%AddedHistory
PFEPfizer IncStock37,029$927.2K0.2%+4,702+14.5%AddedHistory
WVEWave Life Sciences, Inc.SHS135,550$883.8K0.2%+22,000+19.4%AddedHistory
PAASPan American Silver CorpStock29,747$844.8K0.2%+8,463+39.8%AddedHistory
NOVNOV Inc.COM63,876$825.3K0.2%+14,131+28.4%AddedHistory
FDMT4D Molecular Therapeutics, Inc.COM197,458$819.5K0.2%+66,458+50.7%AddedHistory
Sprott FDS Tr85208P303URANIUM MINERS E16,278$761.2K0.2%+4,164+34.4%Added–
LXEOLexeo Therapeutics, Inc.COM178,356$752.7K0.2%+18,158+11.3%AddedHistory
VZLAVizsla Silver Corp.COM NEW250,790$732.3K0.2%+58,303+30.3%AddedHistory
SRPTSarepta Therapeutics, Inc.COM39,400$697.8K0.2%+39,400NewHistory
AUTLAutolus Therapeutics plcSPON ADS294,142$673.6K0.1%+42,468+16.9%AddedHistory
SASeabridge Gold IncCOM44,074$648.3K0.1%00.0%UnchangedHistory
RXRXRecursion Pharmaceuticals, Inc.CL A119,000$610.5K0.1%00.0%UnchangedHistory
VALValaris LtdCL A13,803$606.0K0.1%−6,419−31.7%ReducedHistory
Emx Rty Corp26873J107COM216,968$544.6K0.1%00.0%Unchanged–
SDSandridge Energy IncCOM NEW37,022$400.9K0.1%+13,722+58.9%AddedHistory
NENoble Corp plcORD SHS A14,287$392.0K0.1%00.0%UnchangedHistory
TSHATaysha Gene Therapies, Inc.COM SHS134,900$315.7K0.1%00.0%UnchangedHistory
TDWTidewater IncCOM5,350$255.2K0.1%+5,350NewHistory
SBSWSibanye Stillwater LtdSPONSORED ADR34,040$247.8K0.1%00.0%UnchangedHistory
DYNDyne Therapeutics, Inc.COM27,566$239.3K0.1%00.0%UnchangedHistory
ALXOAlx Oncology Holdings IncCOM509,059$220.6K<0.1%00.0%UnchangedHistory
FATEFate Therapeutics IncCOM111,090$126.6K<0.1%+2,064+1.9%AddedHistory
VYGRVoyager Therapeutics, Inc.COM25,241$78.8K<0.1%+3,596+16.6%AddedHistory

Sold out since Q1 2025 (8)

Positions held at the end of Q1 2025 that are gone from this filing.

Positions of Privium Fund Management B.V. sold out since Q1 2025
SecurityClassShares in Q1 2025Value in Q1 2025% of portfolio in Q1 2025History
SNOWSnowflake Inc.Stock48,000$7.13M1.9%History
NETCloudflare, Inc.CL A COM60,000$6.76M1.8%History
SWTXSpringWorks Therapeutics, Inc.COM123,980$5.47M1.4%History
CPNGCoupang, Inc.CL A81,900$1.83M0.5%History
ALNYAlnylam Pharmaceuticals, Inc.COM5,716$1.54M0.4%History
IMVTImmunovant, Inc.COM72,000$1.23M0.3%History
AIGAmerican International Group, Inc.Stock6,483$563.6K0.1%History
NTLAIntellia Therapeutics, Inc.COM58,709$417.4K0.1%History